Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis

AIMS: We performed this meta-analysis to evaluate the efficacy and safety of glucagon-like peptide-1 receptor-agonists (GLP-1RA) treatment on cardio-metabolic parameters among antipsychotic-treated patients with schizophrenia. METHODS: We searched the Web of Science, Cochrane Central Register of Con...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaity, Abdulrhman, Mostafa Al-dardery, Nada, Albakri, Khaled, Abdelwahab, Omar A., Hefnawy, Mahmoud Tarek, Yousef, Yaman A. S., Taha, Ruaa E., Swed, Sarya, Hafez, Wael, Hurlemann, Rene, Elsayed, Mohamed E. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196269/
https://www.ncbi.nlm.nih.gov/pubmed/37215670
http://dx.doi.org/10.3389/fpsyt.2023.1153648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196269/
https://www.ncbi.nlm.nih.gov/pubmed/37215670
http://dx.doi.org/10.3389/fpsyt.2023.1153648

Ejemplares similares